AROVALT

Serial Number 87679081
606

Registration Progress

Application Filed
Nov 9, 2017
Under Examination
May 22, 2018
Approved for Publication
Mar 27, 2018
Published for Opposition
Mar 27, 2018
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: AROVALT
Previous Owner: PLX PHARMA INC.
Classes: 005

Trademark Image

AROVALT

Basic Information

Serial Number
87679081
Filing Date
November 9, 2017
Published for Opposition
March 27, 2018
Abandonment Date
December 24, 2018
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Dec 24, 2018
Classes
005

Rights Holder

PLX PHARMA INC.

03
Address
8285 El Rio, Suite 130
Houston, TX 77054

Ownership History

PLX PHARMA INC.

Original Applicant
03
Houston, TX

PLX PHARMA INC.

Owner at Publication
03
Houston, TX

Legal Representation

Attorney
Joseph C. Gioconda, Esq.

USPTO Deadlines

All Deadlines Cleared

All 1 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

10 events
Date Code Type Description Documents
Dec 24, 2018 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Dec 24, 2018 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
May 22, 2018 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Mar 27, 2018 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 27, 2018 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 7, 2018 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 21, 2018 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 21, 2018 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 20, 2017 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Nov 13, 2017 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Aspirin-based analgesic, anti-pyretic and anti-inflammatory oral preparations in liquid-filled capsules and oral preparations in liquid-filled capsules for the treatment of pain, fever, arthritis, rheumatoid arthritis, osteoarthritis, cardiovascular disease prevention and cancer prevention
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005